Jeremy Simpson - 18 Mar 2026 Form 3 Insider Report for KAZIA THERAPEUTICS LTD (KZIA)

Role
Program Director
Signature
/s/ Jeffrey Bonacorda, Attorney-in-Fact
Issuer symbol
KZIA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 18:32:35 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simpson Jeremy Program Director THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO AVE, SYDNEY, NSW, AUSTRALIA /s/ Jeffrey Bonacorda, Attorney-in-Fact 18 Mar 2026 0002121674

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KZIA Ordinary Shares Option (Right to Buy) 18 Mar 2026 Ordinary Shares 280,000 $0.1061 Direct F1, F2
holding KZIA Ordinary Shares Option (Right to Buy) 18 Mar 2026 Ordinary Shares 100,000 $0.6651 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares subject to the option ("OS option") vest in four equal semi-annual installments beginning on March 3, 2023, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The OS option was granted on March 3, 2023.
F2 The exercise price is reported in U.S. dollars and reflects the conversion from AUD to USD at an exchange rate of 0.7075 USD per 1.00 AUD as of March 18, 2026.
F3 The Ordinary Shares subject to the OS option vest in four equal annual installments beginning on February 1, 2022, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The OS option was granted on February 1, 2022.

Remarks:

Exhibit 24 - Power of Attorney